Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-4505
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries ; volume:11 ; number:1 ; day:14 ; month:10 ; year:2013 ; pages:1-13 ; date:12.2013
Health research policy and systems ; 11, Heft 1 (14.10.2013), 1-13, 12.2013
- Beteiligte Personen und Organisationen
-
Bigdeli, Maryam
Javadi, Dena
Hoebert, Joelle
Laing, Richard
Ranson, Kent
SpringerLink (Online service)
- DOI
-
10.1186/1478-4505-11-37
- URN
-
urn:nbn:de:1111-2016070910695
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bigdeli, Maryam
- Javadi, Dena
- Hoebert, Joelle
- Laing, Richard
- Ranson, Kent
- SpringerLink (Online service)
Ähnliche Objekte (12)
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
Middle-class composition and growth in middle-income countries
Access to innovative cancer medicines in a middle-income country - the case of Mexico
Inequality, aging, and the middle-income trap
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies
Mining's contribution to low- and middle-income economies
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
Middle-class composition and growth in middle-income countries
Access to innovative cancer medicines in a middle-income country - the case of Mexico
Inequality, aging, and the middle-income trap
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies
Mining's contribution to low- and middle-income economies
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
Middle-class composition and growth in middle-income countries
Access to innovative cancer medicines in a middle-income country - the case of Mexico
Inequality, aging, and the middle-income trap
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies